Ownership history in DCF Advisers, LLC · 11 quarters on record
This page tracks every 13F SEC filing in which DCF Advisers, LLC reported a position in IONIS PHARMACEUTICALS INC (IONS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 103,000 | -5,413 | -5.0% | 2.19% | $8.1M | $79.11 |
| 2025 Q3 | ADDED | 108,413 | +16,663 | +18.2% | 2.28% | $7.1M | $65.42 |
| 2025 Q2 | REDUCED | 91,750 | -3,250 | -3.4% | 1.68% | $3.6M | $39.51 |
| 2025 Q1 | ADDED | 95,000 | +93,500 | +6233.3% | 1.37% | $2.9M | $30.17 |
| 2025 Q1 | REDUCED | 1,500 | -81,382 | -98.2% | 0.02% | $45K | $30.17 |
| 2024 Q4 | ADDED | 82,882 | +80,882 | +4044.1% | 1.40% | $2.9M | $34.96 |
| 2024 Q4 | REDUCED | 2,000 | -37,500 | -94.9% | 0.03% | $70K | $34.96 |
| 2024 Q3 | ADDED | 39,500 | +35,500 | +887.5% | 0.63% | $1.6M | $40.06 |
| 2024 Q3 | REDUCED | 4,000 | -19,000 | -82.6% | 0.06% | $160K | $40.06 |
| 2024 Q2 | ADDED | 23,000 | +22,500 | +4500.0% | 0.56% | $1.1M | — |
As of 2025 Q4 — sorted by position size